These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 25091301

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
    Abanda NN, Djieugoué JY, Lim E, Pefura-Yone EW, Mbacham WF, Vernet G, Penlap VM, Eyangoh SI, Taylor DW, Leke RGF.
    BMC Infect Dis; 2017 May 31; 17(1):379. PubMed ID: 28569148
    [Abstract] [Full Text] [Related]

  • 4. The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.
    Hanrahan CF, Dorman SE, Erasmus L, Koornhof H, Coetzee G, Golub JE.
    PLoS One; 2012 May 31; 7(11):e49898. PubMed ID: 23226229
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis.
    Tukvadze N, Kempker RR, Kalandadze I, Kurbatova E, Leonard MK, Apsindzelashvili R, Bablishvili N, Kipiani M, Blumberg HM.
    PLoS One; 2012 May 31; 7(2):e31563. PubMed ID: 22347495
    [Abstract] [Full Text] [Related]

  • 8. Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand.
    Anek-Vorapong R, Sinthuwattanawibool C, Podewils LJ, McCarthy K, Ngamlert K, Promsarin B, Varma JK.
    BMC Infect Dis; 2010 May 20; 10():123. PubMed ID: 20487550
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant Tuberculosis.
    de Vos M, Derendinger B, Dolby T, Simpson J, van Helden PD, Rice JE, Wangh LJ, Theron G, Warren RM.
    J Clin Microbiol; 2018 Sep 20; 56(9):. PubMed ID: 29976588
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of GenoType® MTBDRplus assay for rapid detection of drug susceptibility testing of multi-drug resistance tuberculosis in Northern India.
    Maurya AK, Umrao J, Singh AK, Kant S, Kushwaha RA, Dhole TN.
    Indian J Pathol Microbiol; 2013 Sep 20; 56(2):139-43. PubMed ID: 24056651
    [Abstract] [Full Text] [Related]

  • 11. Profile of drug-resistant-conferring mutations among new and previously treated pulmonary tuberculosis cases from Aligarh region of Northern India.
    Ahmed S, Shukla I, Fatima N, Varshney SK, Shameem M, Tayyaba U.
    Int J Mycobacteriol; 2018 Sep 20; 7(4):315-327. PubMed ID: 30531028
    [Abstract] [Full Text] [Related]

  • 12. Molecular diagnosis of MDR-TB using GenoType MTBDRplus 96 assay in Ibadan, Nigeria.
    Kehinde AO, Adebiyi EO.
    Niger J Physiol Sci; 2013 Dec 20; 28(2):187-91. PubMed ID: 24937395
    [Abstract] [Full Text] [Related]

  • 13. Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India.
    Yadav RN, Singh BK, Sharma SK, Sharma R, Soneja M, Sreenivas V, Myneedu VP, Hanif M, Kumar A, Sachdeva KS, Paramasivan CN, Vollepore B, Thakur R, Raizada N, Arora SK, Sinha S.
    PLoS One; 2013 Dec 20; 8(9):e72036. PubMed ID: 24039735
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MTBDRplus results correlate with treatment outcome in previously treated tuberculosis patients.
    Huang FL, Jin JL, Chen S, Zhou Z, Diao N, Huang HQ, Liu W, Wang Q, Weng XH, Chaisson RE, Zhang Y, Zhang WH.
    Int J Tuberc Lung Dis; 2015 Mar 20; 19(3):319-25, i-ii. PubMed ID: 25686141
    [Abstract] [Full Text] [Related]

  • 16. Implementation of genotype MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South Africa.
    Jacobson KR, Theron D, Kendall EA, Franke MF, Barnard M, van Helden PD, Victor TC, Streicher EM, Murray MB, Warren RM.
    Clin Infect Dis; 2013 Feb 20; 56(4):503-8. PubMed ID: 23090928
    [Abstract] [Full Text] [Related]

  • 17. Frequency of multi-drug resistance and mutations in Mycobacterium tuberculosis isolates from Punjab state of India.
    Singhal R, Arora J, Sah GC, Bhalla M, Sarin R, Prasad Myneedu V.
    J Epidemiol Glob Health; 2017 Sep 20; 7(3):175-180. PubMed ID: 28756826
    [Abstract] [Full Text] [Related]

  • 18. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia.
    Skenders GK, Holtz TH, Riekstina V, Leimane V.
    Int J Tuberc Lung Dis; 2011 Nov 20; 15(11):1546-52, i. PubMed ID: 22008771
    [Abstract] [Full Text] [Related]

  • 19. Detecting mutation pattern of drug-resistant Mycobacterium tuberculosis isolates in Himachal Pradesh using GenoType(®) MTBDRplus assay.
    Thakur C, Kumar V, Gupta AK.
    Indian J Med Microbiol; 2015 Nov 20; 33(4):547-53. PubMed ID: 26470962
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y, Mathema B, Zhao Q, Zheng X, Li D, Jiang W, Wang W, Xu B.
    Tuberculosis (Edinb); 2016 Mar 20; 97():18-25. PubMed ID: 26980491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.